Cargando...
Ranibizumab Combined With Low-Dose Sorafenib for Exudative Age-Related Macular Degeneration
Angiogenesis is a common factor in the pathogenesis of cancer and in exudative age-related macular degeneration (AMD). Therefore, angiogenesis inhibition has been developed as a therapeutic strategy. We report 2 cases of recurrent exudative AMD in which oral sorafenib, a tyrosine kinase inhibitor ap...
Gardado en:
| Main Authors: | , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
2008
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2763274/ https://ncbi.nlm.nih.gov/pubmed/18241635 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1600-0420.2007.01014.x |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|